UK Regulator Approves Oral COVID-19 Medication Paxlovid

MOSCOW (Sputnik) - The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) announced on Friday that the new oral treatment Paxlovid has been authorised for people with mild to moderate COVID-19 to reduce the risk of developing severe disease.